Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204) Cash Flow for Dividends : ¥-0.5 Mil (TTM As of Dec. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Staidson (Beijing) Biopharmaceuticals Co Cash Flow for Dividends?

Staidson (Beijing) Biopharmaceuticals Co's cash flow for dividends for the three months ended in Dec. 2024 was ¥0.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2024 was ¥-0.5 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Staidson (Beijing) Biopharmaceuticals Co's quarterly payment of dividends declined from Jun. 2024 (¥-0.3 Mil) to Sep. 2024 (¥-0.0 Mil) and declined from Sep. 2024 (¥-0.0 Mil) to Dec. 2024 (¥0.0 Mil).

Staidson (Beijing) Biopharmaceuticals Co's annual payment of dividends increased from Dec. 2022 (¥0.0 Mil) to Dec. 2023 (¥-1.0 Mil) but then declined from Dec. 2023 (¥-1.0 Mil) to Dec. 2024 (¥-0.5 Mil).

Staidson (Beijing) Biopharmaceuticals Co Cash Flow for Dividends Historical Data

The historical data trend for Staidson (Beijing) Biopharmaceuticals Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Staidson (Beijing) Biopharmaceuticals Co Cash Flow for Dividends Chart

Staidson (Beijing) Biopharmaceuticals Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash Flow for Dividends

Get a 7-Day Free Trial

-0.86

-0.32

-1.02

-0.54

Staidson (Beijing) Biopharmaceuticals Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Cash Flow for Dividends	Get a 7-Day Free Trial															-	-0.26	-0.25	-0.04	-

Staidson (Beijing) Biopharmaceuticals Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.5 Mil.

Staidson (Beijing) Biopharmaceuticals Co Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Staidson (Beijing) Biopharmaceuticals Co's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Staidson (Beijing) Biopharmaceuticals Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Staidson (Beijing) Biopharmaceuticals Co Ltd (SZSE:300204) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

N/A

Address

Rongjing Dong Street, No 5 Beijing Economic and Technological Development Zone, Beijing, CHN, 100176

Website

http://www.staidson.com

Staidson (Beijing) Biopharmaceuticals Co Ltd is a pharmaceutical company mainly engaged in the research, development, production, and sale of biological products in China. Its products include mouse nerve growth factor injection, intravenous compound polyethylene glycol electrolyte powder solution, gliclazide, nabumetone, and aspirin.

Executives

Zhang Hong Shan	Supervisors
Zheng Hong	Supervisors
Cheng Jiang Hong	Executives
Feng Yu Jing	Executives
Ma Li Na	Secretary, Director
Zhou Zhi Wen	Director
Wang Huan	Securities Affairs Representative
Zhang Rong Qin	Executives
Xu Jiang Ping	Executives
Cao Hai Yan	Supervisors
Sun Yan Fang	Executives
Jiang Li Xin	Director
Gu Jian Ping	Director
Xu Xiang Qing	Supervisors
Gu Zhen Qi	Director

Staidson (Beijing) Biopharmaceuticals Co Headlines

No Headlines